ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Student in an Organized Health Care Education/Training Program

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 274

$520K Total Retail Price of All Prescriptions

Rank: 4 out of 274

450 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 657 612 103 1 2
LOVASTATIN 645 591 114 2 17
METFORMIN HCL 536 475 84 3 7
LEVOTHYROXINE SODIUM 499 456 76 4 5
AMLODIPINE BESYLATE 351 300 63 5 4
GABAPENTIN 252 230 50 6 18
HYDROCODONE-ACETAMINOPHEN 243 175 54 S3 7 1
FUROSEMIDE 238 233* 45 8 13
ALENDRONATE SODIUM 232 227* 49 9 15
ATENOLOL 226 221* 46 10 8
SIMVASTATIN 223 206 43 11 3
HYDROCHLOROTHIAZIDE 221 207 45 12 9
NORTRIPTYLINE HCL 217 212* 57 13 36
OMEPRAZOLE 210 205* 53 14 10
METOPROLOL TARTRATE 183 160 30 15 12
GLIPIZIDE 180 163 33 16 16
PANTOPRAZOLE SODIUM 177 159 41 17 33
LOSARTAN POTASSIUM 172 155 25 18 11
ATORVASTATIN CALCIUM 164 159* 28 19 6
BENAZEPRIL HCL 143 130 20 20 27
METOPROLOL SUCCINATE 126 105 23 21 35
CLOPIDOGREL 123 123 20 22 38
NIFEDIPINE ER 123 118* 20 22 93
WARFARIN SODIUM 119 119 27 24 22
CITALOPRAM HBR 119 89 28 24 30
CARVEDILOL 115 110* 17 26 34
ALPRAZOLAM 113 108* 32 B 27 32
MELOXICAM 106 95 27 28 37
PRAVASTATIN SODIUM 100 95* 19 29 21
DILTIAZEM 24HR ER 95 95 21 30 110
PROPRANOLOL HCL 91 91 13 31 114
TRAMADOL HCL 90 51 16 32 31
TAMSULOSIN HCL 89 84* 24 33 24
ZOLPIDEM TARTRATE 88 83* 19 34 28
CLONIDINE HCL 87 75 14 35 119
PAROXETINE HCL 84 79* 14 36 124
DICLOFENAC SODIUM 79 60 34 37 118
ALLOPURINOL 74 69* 18 38 59
MONTELUKAST SODIUM 72 72 11 39 74
PROAIR HFA 69 69 19 40 20
FINASTERIDE 67 62* 12 41 97
CLONIDINE 66 <11 <11 42 172
LANTUS 63 <11 <11 43 91
DONEPEZIL HCL 62 62 11 44 39
POTASSIUM CHLORIDE 62 57* 12 44 112
SPIRIVA 62 57* 18 44 75
NAMENDA 62 <11 <11 44 61
FLUTICASONE PROPIONATE 61 56* 38 48 14
OXYBUTYNIN CHLORIDE 60 55* 12 49 181
LABETALOL HCL 60 55* 12 49 181
ISOSORBIDE MONONITRATE ER 59 59 12 51 143
VESICARE 58 <11 <11 52 185
LEVEMIR FLEXPEN 56 51* 12 53 187
KLOR-CON M20 56 <11 <11 53 187
MECLIZINE HCL 53 53 24 55 197
DIOVAN 52 52 12 56 86
AMITRIPTYLINE HCL 52 30 12 R 56 198
TRAZODONE HCL 51 37 16 58 26
BENICAR 50 37 11 59 152
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.